<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We aim to investigate the efficacy and safety of the treatment with fully matched allogeneic hematopoietic stem cell transplants for children with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA) in the first prospective trial in China </plain></SENT>
<SENT sid="1" pm="."><plain>Six SAA children received allogeneic hematopoietic stem cell transplantation combined with chemotherapy </plain></SENT>
<SENT sid="2" pm="."><plain>Five patients had successful engraftment while the sixth child regained <z:mpath ids='MPATH_458'>normal</z:mpath> peripheral blood counts consistent with spontaneous autologous hematopoiesis </plain></SENT>
<SENT sid="3" pm="."><plain>Mean duration of follow-up was 2.75 years, and survival was 83%(5/6) </plain></SENT>
<SENT sid="4" pm="."><plain>The results indicated that allogeneic hematopoietic stem cell transplantation is a good option for the treatment of children with severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> </plain></SENT>
</text></document>